What condition is terazosin used to treat?

A. Heart failure: Terazosin is not primarily indicated for heart failure management. While it may have some vasodilatory effects that could theoretically reduce afterload, it is not a standard treatment for heart failure and does not address the core pathophysiology. B. Peripheral vascular disease: Terazosin does not directly treat peripheral vascular disease. Its mechanism of action as an alpha-1 adrenergic blocker primarily targets vascular smooth muscle to lower systemic blood pressure rather than improve blood flow to peripheral tissues. C. Pulmonary edema: Pulmonary edema is usually managed with diuretics, oxygen therapy, and addressing the underlying cause. Terazosin does not have an acute role in managing fluid overload or pulmonary congestion. D. Chronic hypertension: Terazosin is an alpha-1 adrenergic blocker used to treat chronic hypertension by relaxing vascular smooth muscle, reducing peripheral vascular resistance, and lowering blood pressure. It is commonly prescribed for long-term blood pressure control, especially in clients who may also have benign prostatic hyperplasia.